Department of Nephrology, Huzhou Central Hospital, Affiliated Central Hospital Huzhou University, No. 1558, Sanhuan North Road, Wuxing District, Huzhou, Zhejiang 313000, China.
Comput Math Methods Med. 2023 Feb 22;2023:9450752. doi: 10.1155/2023/9450752. eCollection 2023.
Chronic kidney disease (CKD) is a clinical collective term for kidney disease with glomerular filtration rate (GFR) < 60 mL/min for more than three months due to various factors and is usually associated with coronary heart disease and is also an independent risk factor for coronary heart disease. This study is aimed at systematically reviewing the influence of CKD on the outcomes of patients after percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs).
The Cochrane Library, PubMed, Embase, China biomedical literature database (SinoMed), China National Knowledge Infrastructure, and Wanfang database were searched for case-control studies on the influence of CKD on outcomes after PCI for CTOs. After screening the literature, extracting data, and evaluating the quality of literature, RevMan 5.3 software was used for meta-analysis.
There were 11 articles with a total of 558,440 patients included. Meta-analysis results indicated that left ventricular ejection fraction (LVEF) level, diabetes, smoking, hypertension, coronary artery bypass grafting, angiotensin converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB), -blockers, age, and renal insufficiency were the factors affecting outcomes after PCI for CTOs [risk ratio and 95% confidence interval were: 0.88 (0.86, 0.90), 0.96 (0.95, 0.96), 0.76 (0.59, 0.98), 1.39 (0.89, 2.16), 0.73 (0.38, 1.40), 0.24 (0.02, 3.9), 0.78 (0.77, 0.79), 0.81 (0.80, 0.82), and 1.50 (0.47, 4.79)].
LVEF level, diabetes, smoking, hypertension, coronary artery bypass grafting, ACEI/ARB, -blockers, age, renal insufficiency, etc. are important risk factors for outcomes after PCI for CTOs. Controlling these risk factors is of great significance for the prevention, treatment, and prognosis of CKD.
慢性肾脏病(CKD)是指由于各种因素导致肾小球滤过率(GFR)<60ml/min 持续超过三个月而引起的肾脏疾病的临床统称,通常与冠心病有关,也是冠心病的独立危险因素。本研究旨在系统回顾 CKD 对经皮冠状动脉介入治疗(PCI)慢性完全闭塞(CTO)患者结局的影响。
检索 Cochrane 图书馆、PubMed、Embase、中国生物医学文献数据库(SinoMed)、中国知网(CNKI)和万方数据库中关于 CKD 对 CTO 患者 PCI 后结局影响的病例对照研究。筛选文献、提取数据并评价文献质量后,采用 RevMan 5.3 软件进行荟萃分析。
共纳入 11 篇文献,总计 558440 例患者。Meta 分析结果表明,左心室射血分数(LVEF)水平、糖尿病、吸烟、高血压、冠状动脉旁路移植术、血管紧张素转换酶抑制剂(ACEI)/血管紧张素受体阻滞剂(ARB)、β受体阻滞剂、年龄和肾功能不全是影响 CTO 患者 PCI 后结局的因素[风险比及其 95%置信区间为:0.88(0.86,0.90)、0.96(0.95,0.96)、0.76(0.59,0.98)、1.39(0.89,2.16)、0.73(0.38,1.40)、0.24(0.02,3.9)、0.78(0.77,0.79)、0.81(0.80,0.82)和 1.50(0.47,4.79)]。
LVEF 水平、糖尿病、吸烟、高血压、冠状动脉旁路移植术、ACEI/ARB、β受体阻滞剂、年龄、肾功能不全等是 CTO 患者 PCI 后结局的重要危险因素。控制这些危险因素对 CKD 的预防、治疗和预后具有重要意义。